The integrator branded a Boeing 777 freighter to function as a flying ambassador of its focus on Life Science and Healthcare Logistics (LSH). The move is part of DHL’s cold chain network expansion, designed to reshape the supply of temperature-sensitive medicines, vaccines, pharmaceutical products and cell & gene therapies.
The B777 freighter sports DHL livery but belongs to Michigan-based Kalitta Air. Last week, it began operating flights between the pharma hotspots Brussels (BRU) and Cincinnati (CVG), with additional routes in Europe, the Middle East, Asia, and Latin America to follow soon. The BRU-CVG corridor links the U.S. Midwest, home to leading pharma companies, directly with one of Europe’s most advanced life sciences ecosystems in Belgium. By avoiding coastal congestion, the lane provides a seamless, temperature-controlled pathway for high-value biologics and time-critical cell and gene therapies. At the Brussels end, the route is supported by BRUcargo’s 45,000 m² of pharma-only zones, delivering clinical-grade integrity end to end. Together, this infrastructure establishes a resilient connection between two of the world’s most important healthcare markets, emphasizes DHL in a release.
No sub-fleet for cool products
Depending on network requirements, the aircraft will also be deployed on other global routes in line with DHL’s expansion of its logistics capacities in the life sciences and healthcare sectors.
A spokesperson confirmed to CargoForwarder Global that there are no plans to establish a separate sub-fleet for cool products. Instead, DHL is improving uplift flexibility across the entire network by optimizing routes and prioritizing capacity on high-demand lanes to better support the transport of temperature-critical life sciences and healthcare items. He added that the aircraft does not only transport these kinds of sensitive products but also carries other express and general cargo shipments as part of the larger DHL network.
30+ GDP-compliant hubs
Countries prioritized for further expansion of the Airfreight Cold Chain Network include India, Brazil, Singapore, Germany, Japan, South Korea, the United States, and Ireland. These routes are designed to meet strict regulatory requirements and maintain product quality throughout the entire supply chain. Once established, the expanded network will include more than 30 GDP-compliant aviation hubs and gateways. It will support DHL’s mission to strengthen global health logistics and meet rising demand for fast, reliable, temperature-controlled transport of pharmaceutical products and medical supplies. Patient safety remains central to the service, stresses DHL. Combined with significant investments in temperature-controlled ground infrastructure, the network reduces reliance on heavy, costly packaging and refrigerated air freight containers, offering an economical service focused on quality and minimizing temperature excursions.
